Spyre's SPY003 meets primary endpoint in Phase 2 UC trial

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/21/2026

1. SPY
2. TSLA
3. AMC
4. WBD
5. MSFT
6. ACN
7. FFAI
8. PAA
9. TLT
10. PAGP

Go back to Spyre's SPY003 meets primary endpoint in Phase 2 UC trial
(NASDAQ: SYRE) Delayed: 90.25 --0 (-0%)
Previous Close $90.25    52 Week High $ 
Open $90.25    52 Week Low $ 
Day High $90.25    P/E N/A 
Day Low $90.25    EPS $ 
Volume 21